Clinical Trials Directory

Trials / Completed

CompletedNCT01016184

Influence of Vitamin D Treatment on Multi-systemic Functions in Young Men With Vitamin D Deficiency Due to Work Conditions

Prospective, Randomized, Double Blind Placebo Controled Clinical Trial to Assess the Multi- Systemic Effect of Vitamin D Supplementation on Young Men With Vitamin D Deficiency

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
358 (actual)
Sponsor
Rambam Health Care Campus · Academic / Other
Sex
Male
Age
25 Years – 65 Years
Healthy volunteers
Accepted

Summary

Vitamin D has multiple systemic effects: bone and calcium metabolism, muscle function, insulin responsiveness, body-composition regulation, cell differentiation, and the immune system. Proper status of vitamin D is found to be related to risk reduction in hypertension, cardiac and vascular diseases, autoimmune diseases, and others. Furthermore, vitamin D supplementation resulted in improved endothelial function. Limited sun exposure may lead to vitamin D deficiency, and it may be assumed that modern life styles lead to a lack of sun exposure. Long work-days may be the primary risk factor for vitamin D deficiency. The purpose of this research is to study the effect of vitamin D treatment on multi systemic functions in young healthy men with vitamin D deficiency due to working conditions.

Detailed description

The study has 2 stages: first stage would be survey of 400 employees, who will fill out a questionnaire to identify occupational and demographic risk factors, a nutritional questionnaire, and data from periodic checkups will be collected. Participants will sign a consent form for vitamin D level determinations, and for freezing blood samples. From this survey, the participants that have vitamin D deficiency (25(OH)D levels \< 20 ng/ml) will continue to the second stage of the study - administration of vitamin D or placebo. Participants in the interventional study will sign an additional consent form. Length of follow-up: one year. All parameters will be tested at 0, 6, and 12 months.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin DOral vitamin D 100,000 IU
DIETARY_SUPPLEMENTPlaceboPlacebo

Timeline

Start date
2009-09-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2009-11-19
Last updated
2013-02-01

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01016184. Inclusion in this directory is not an endorsement.